Table 8. Factors associated with the readiness of the facilities to provide DM management at the PHCU adjusted for confounding variables.
Variables | COR [95% CI] | AOR [95% CI] |
---|---|---|
Facility type | ||
Health centre | 1.0 | 1.0 |
Primary Hospital | 4.958 [1.4–17.5]* | 2.2 [0.5–9.5] |
General Hospital | – | – |
Others | 8.5 [0.7–101.6] | 11.9 [0.8–0.186.0] |
Facilities location | ||
Rural | 1.0 | 1.0 |
Urban | 9.6 [3.2–28.5]** | 11.1 [3.13–39.36]** |
Guideline for NCD | ||
Not available | 1.0 | 1.0 |
Available | 0.055 [0.013–0.22]** | 0.31 [0.004–0.231]** |
Staff trained for DM management | ||
Trained | 1.0 | 1.0 |
Not trained | 0.18 [0.004–0.08]** | 0.055 [0.009–0.336]* |
Adult weight scale | ||
Not available | 1 | 1 |
Available | 0.000 | - |
Measuring tape (ref.) | ||
Not available | 1.0 | 1.0 |
Available | 0.057 [0.017–0.18]** | 0.055 [0.009–0.336]** |
Stadio-meter | ||
Available | 1 | 1 |
Not available | - | - |
Blood glucose test | ||
Not available | 1 | 1 |
Available | 0.04 [0.002–0.156]** | 0.044 [0.005–0.339]** |
Urine protein and ketone | ||
Not available | 1 | 1 |
Available | 0.023 [0.003–0.182]** | 0.054 [0.006–0.472]** |
Metformin | ||
Available | 1 | 1 |
Not available | 0.006 [0.001–0.051]** | 0.003 [0.000–0.066]** |
Glibenclamid | ||
Not available | 1 | 1 |
Available | 0.008 [0.001–0.67] | 0.008 [0.001–0.091] |
Insulin | ||
Not available | 1 | 1 |
Available | 0.19 [0.005–0.77] | 0.018 [0.003–0.121]** |
Glucose 40% | ||
Not available | 1 | 1 |
Available | - | - |
Gliclazide/Glipizide | ||
Not available | 1 | 1 |
Available | 0.193 [0.017–2.237] | 0.459 [0.011–19.545] |
Notes:
P value ≤ 0.05.
P value ≤ 0.01.